3
- Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar The New York Times
- Eli Lilly shares surge on new obesity pill data. What it means for the stock from here CNBC
- Lilly’s oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial | Eli Lilly and Company Eli Lilly and Company
- How a New Weight-Loss Pill Could Transform Health Time Magazine
- Weight loss in a pill? Eli Lilly just took a big step closer to making it happen Business Insider
